Behrooz Johari

1.6k total citations
72 papers, 1.3k citations indexed

About

Behrooz Johari is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Behrooz Johari has authored 72 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 24 papers in Biomedical Engineering and 19 papers in Biomaterials. Recurrent topics in Behrooz Johari's work include Nanoplatforms for cancer theranostics (17 papers), Nanoparticle-Based Drug Delivery (15 papers) and RNA Interference and Gene Delivery (14 papers). Behrooz Johari is often cited by papers focused on Nanoplatforms for cancer theranostics (17 papers), Nanoparticle-Based Drug Delivery (15 papers) and RNA Interference and Gene Delivery (14 papers). Behrooz Johari collaborates with scholars based in Iran, United States and Türkiye. Behrooz Johari's co-authors include Mahmoud Gharbavi, Mehdi Kadivar, Hamid Madanchi, Ali Sharafi, Hamed Rezaeejam, Navid Mousazadeh, Mohammad Moradi, Majid Lotfinia, Hossein Danafar and Elham Rismani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Pharmaceutics.

In The Last Decade

Behrooz Johari

67 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Behrooz Johari Iran 23 498 413 317 284 140 72 1.3k
Dipesh Baradia India 13 650 1.3× 290 0.7× 437 1.4× 243 0.9× 132 0.9× 16 1.4k
Rang‐Woon Park South Korea 18 717 1.4× 359 0.9× 398 1.3× 191 0.7× 66 0.5× 39 1.6k
Flávia Sousa Portugal 24 574 1.2× 531 1.3× 701 2.2× 121 0.4× 132 0.9× 37 1.6k
Imran Vhora India 21 877 1.8× 386 0.9× 617 1.9× 325 1.1× 157 1.1× 25 1.8k
Ali Aghebati‐Maleki Iran 16 423 0.8× 234 0.6× 179 0.6× 294 1.0× 128 0.9× 30 1.2k
Keren Miller Israel 22 402 0.8× 229 0.6× 303 1.0× 276 1.0× 127 0.9× 36 1.4k
Arash Hatefi United States 25 1.1k 2.2× 377 0.9× 630 2.0× 238 0.8× 124 0.9× 57 2.1k
Guixiang Zhang China 21 444 0.9× 264 0.6× 243 0.8× 68 0.2× 133 0.9× 83 1.4k
Lixia Huang China 19 281 0.6× 220 0.5× 199 0.6× 259 0.9× 54 0.4× 66 1.1k

Countries citing papers authored by Behrooz Johari

Since Specialization
Citations

This map shows the geographic impact of Behrooz Johari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behrooz Johari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behrooz Johari more than expected).

Fields of papers citing papers by Behrooz Johari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behrooz Johari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behrooz Johari. The network helps show where Behrooz Johari may publish in the future.

Co-authorship network of co-authors of Behrooz Johari

This figure shows the co-authorship network connecting the top 25 collaborators of Behrooz Johari. A scholar is included among the top collaborators of Behrooz Johari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behrooz Johari. Behrooz Johari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gharbavi, Mahmoud, et al.. (2025). Methotrexate-conjugated silver nanoparticles enhance chemoradiotherapy effects on U87 human glioblastoma multiforme cells: As a radiosensitizer agent to improve X-irradiation efficacy. Journal of Drug Delivery Science and Technology. 107. 106791–106791. 2 indexed citations
3.
4.
Gharbavi, Mahmoud, et al.. (2025). Green synthesis of silver nanoparticles coated with methotrexate-conjugated polyvinyl alcohol: As potential nanosystem for chemo/radiotherapy. Journal of Drug Delivery Science and Technology. 105. 106643–106643. 3 indexed citations
5.
Gharbavi, Mahmoud, et al.. (2024). Zinc nanoparticles coated with doxorubicin-conjugated alginate as a radiation sensitizer in triple-negative breast cancer cells. International Journal of Pharmaceutics. 659. 124285–124285. 16 indexed citations
6.
7.
Gharbavi, Mahmoud, et al.. (2023). Selenium‐doped albumin nanoparticles enhance tamoxifen‐induced anticancer effects in 4T‐1 mouse breast cancer cells. Applied Organometallic Chemistry. 38(2). 9 indexed citations
8.
Mousazadeh, Navid, Mahmoud Gharbavi, Hamid Rashidzadeh, et al.. (2022). Anticancer Evaluation of Methotrexate and Curcumin-Coencapsulated Niosomes Against Colorectal Cancer Cell Lines. Nanomedicine. 17(4). 201–217. 37 indexed citations
9.
10.
Lakpour, Niknam, et al.. (2021). Association of MTHFR C677T and MTRR A66G GenePolymorphisms with Iranian Male Infertility and Its Effect onSeminal Folate and Vitamin B12. SHILAP Revista de lepidopterología. 3 indexed citations
11.
12.
13.
14.
Gharbavi, Mahmoud, et al.. (2020). Hybrid of niosomes and bio-synthesized selenium nanoparticles as a novel approach in drug delivery for cancer treatment. Molecular Biology Reports. 47(9). 6517–6529. 52 indexed citations
15.
Gharbavi, Mahmoud, et al.. (2020). Cholesterol‐conjugated bovine serum albumin nanoparticles as a tamoxifen tumor‐targeted delivery system. Cell Biology International. 44(12). 2485–2498. 26 indexed citations
16.
Hosseini‐khah, Zahra, et al.. (2019). Association between PPARGC1A single nucleotide polymorphisms and increased risk of nonalcoholic fatty liver disease among Iranian patients with type 2 diabetes mellitus. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(4). 1089–1094. 8 indexed citations
17.
18.
Dinarvand, Rassoul, et al.. (2018). Preparation and investigation of indirubin‐loaded SLN nanoparticles and their anti‐cancer effects on human glioblastoma U87MG cells. Cell Biology International. 43(1). 2–11. 40 indexed citations
19.
Johari, Behrooz, et al.. (2017). H2O2-Preconditioned Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Liver Regeneration in Acute Liver Failure-Induced Mice. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Johari, Behrooz & Jamil Zargan. (2017). Simultaneous targeted inhibition of Sox2‐Oct4 transcription factors using decoy oligodeoxynucleotides to repress stemness properties in mouse embryonic stem cells. Cell Biology International. 41(12). 1335–1344. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dipesh Baradia Breakdown of academic impact, for papers by Rang‐Woon Park Breakdown of academic impact, for papers by Flávia Sousa Breakdown of academic impact, for papers by Imran Vhora Breakdown of academic impact, for papers by Ali Aghebati‐Maleki Breakdown of academic impact, for papers by Keren Miller Breakdown of academic impact, for papers by Arash Hatefi Breakdown of academic impact, for papers by Guixiang Zhang Breakdown of academic impact, for papers by Lixia Huang
Rankless by CCL
2026